JLK Inc Relative Valuation - JLK Inc - Alpha Spread
J

JLK Inc
KOSDAQ:322510

Watchlist Manager
JLK Inc
KOSDAQ:322510
Watchlist
Price: 12 950 KRW 7.92% Market Closed
Market Cap: 205.4B KRW
Have any thoughts about
JLK Inc?
Write Note

Relative Value

The Relative Value of one JLK Inc stock under the Base Case scenario is 300.21 KRW. Compared to the current market price of 12 950 KRW, JLK Inc is Overvalued by 98%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
300.21 KRW
Overvaluation 98%
Relative Value
Price
J
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
19
vs Industry
2
Median 3Y
27.9
Median 5Y
29.7
Industry
2.3
vs History
vs Industry
Median 3Y
-14
Median 5Y
-14.5
Industry
22.4
vs History
vs Industry
Median 3Y
-18.6
Median 5Y
-26.4
Industry
14.3
vs History
vs Industry
Median 3Y
-30.5
Median 5Y
-28.9
Industry
20.5
vs History
3
vs Industry
2
Median 3Y
5.1
Median 5Y
4.7
Industry
2.1
vs History
19
vs Industry
2
Median 3Y
28.7
Median 5Y
28.9
Industry
2.4
vs History
vs Industry
3
Median 3Y
-63.8
Median 5Y
-62.9
Industry
4.9
vs History
vs Industry
Median 3Y
-16.6
Median 5Y
-16.5
Industry
12.5
vs History
vs Industry
Median 3Y
-14.3
Median 5Y
-14.7
Industry
16.8
vs History
vs Industry
Median 3Y
-18.7
Median 5Y
-26.5
Industry
14.2
vs History
vs Industry
Median 3Y
-17
Median 5Y
-13.7
Industry
18.2
vs History
21
vs Industry
10
Median 3Y
3.7
Median 5Y
3.8
Industry
1.9

Multiples Across Competitors

Competitors Multiples
JLK Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
JLK Inc
KOSDAQ:322510
222.8B KRW 137.7 -19.8 -24 -22.1
US
Veeva Systems Inc
NYSE:VEEV
34.8B USD 13.5 56.5 47.7 50.6
US
Cerner Corp
LSE:0R00
31.3B USD 5.4 53.1 21.9 43.2
AU
Pro Medicus Ltd
ASX:PME
18B AUD 108.1 217.2 151.6 151.6
US
Doximity Inc
NYSE:DOCS
7.6B USD 15.4 47.3 35.9 38
JP
M3 Inc
TSE:2413
986.6B JPY 4 22.4 11.9 13.6
US
Inspire Medical Systems Inc
NYSE:INSP
6.3B USD 9 1 048.4 -562.1 -412.3
SE
Sectra AB
STO:SECT B
51.6B SEK 28.5 115.4 -68.9 -68.9
US
Waystar Holding Corp
NASDAQ:WAY
4.6B USD 5.3 -62 15.4 51.5
US
Evolent Health Inc
NYSE:EVH
3.6B USD 1.5 -33.5 34.1 -1 680.6
US
Vocera Communications Inc
F:V00
2.4B EUR 11.4 -315.3 257 4 115.5
P/E Multiple
Earnings Growth
KR
J
JLK Inc
KOSDAQ:322510
Average P/E: 222.9
Negative Multiple: -19.8
N/A
US
Veeva Systems Inc
NYSE:VEEV
56.5
139%
US
C
Cerner Corp
LSE:0R00
53.1
N/A
AU
Pro Medicus Ltd
ASX:PME
217.2
109%
US
Doximity Inc
NYSE:DOCS
47.3
62%
JP
M3 Inc
TSE:2413
22.4
26%
US
Inspire Medical Systems Inc
NYSE:INSP
1 048.4
N/A
SE
Sectra AB
STO:SECT B
115.4
81%
US
W
Waystar Holding Corp
NASDAQ:WAY
Negative Multiple: -62 N/A
US
Evolent Health Inc
NYSE:EVH
Negative Multiple: -33.5 N/A
US
V
Vocera Communications Inc
F:V00
Negative Multiple: -315.3 N/A
EV/EBITDA Multiple
EBITDA Growth
KR
J
JLK Inc
KOSDAQ:322510
Average EV/EBITDA: 71.9
Negative Multiple: -24
N/A
US
Veeva Systems Inc
NYSE:VEEV
47.7
220%
US
C
Cerner Corp
LSE:0R00
21.9
N/A
AU
Pro Medicus Ltd
ASX:PME
151.6
85%
US
Doximity Inc
NYSE:DOCS
35.9
68%
JP
M3 Inc
TSE:2413
11.9
28%
US
Inspire Medical Systems Inc
NYSE:INSP
Negative Multiple: -562.1 N/A
SE
Sectra AB
STO:SECT B
Negative Multiple: -68.9 N/A
US
W
Waystar Holding Corp
NASDAQ:WAY
15.4
N/A
US
Evolent Health Inc
NYSE:EVH
34.1
189%
US
V
Vocera Communications Inc
F:V00
257
N/A
EV/EBIT Multiple
EBIT Growth
KR
J
JLK Inc
KOSDAQ:322510
Average EV/EBIT: 637.7
Negative Multiple: -22.1
N/A
US
Veeva Systems Inc
NYSE:VEEV
50.6
231%
US
C
Cerner Corp
LSE:0R00
43.2
N/A
AU
Pro Medicus Ltd
ASX:PME
151.6
67%
US
Doximity Inc
NYSE:DOCS
38
71%
JP
M3 Inc
TSE:2413
13.6
N/A
US
Inspire Medical Systems Inc
NYSE:INSP
Negative Multiple: -412.3 N/A
SE
Sectra AB
STO:SECT B
Negative Multiple: -68.9 N/A
US
W
Waystar Holding Corp
NASDAQ:WAY
51.5
N/A
US
Evolent Health Inc
NYSE:EVH
Negative Multiple: -1 680.6
2 184%
US
V
Vocera Communications Inc
F:V00
4 115.5
N/A

See Also

Discover More
Back to Top